Fiona has a wide range of practical experience and specialises in patents in the chemical, pharmaceutical and healthcare fields. Fiona's experience includes provision of advice and drafting patent applications in relation to pharmaceuticals, colour chemicals, pigments, polymer chemistry, personal care products, chemical synthesis and processes as well as medical devices.
Fiona's specialist areas of patent practice are predominantly within the chemical, pharmaceutical, medical devices and healthcare spheres, and she also brings her wide-ranging practical experience to bear for clients with innovative technologies in other areas including chemical engineering, physics as well as in relation to registered designs for new products.
With extensive practical patent experience gained from 24 years in practice both at HGF and previously in industry, Fiona brings a customer-focussed approach to her work. Her practice is predominantly related to the chemical, pharmaceutical and healthcare fields and specifically includes pharmaceuticals, colour chemicals and pigments, polymer chemistry, chemical synthesis and processes, as well as formulations for personal care products, and also medical devices. Her clients range from UK start-up companies and SMEs, to world leading universities and multi-national organisations with substantial patent portfolios.
Prior to joining HGF, Fiona worked in industry for 18 years, initially in research before qualifying as a patent attorney. Whilst working in the patent department of a global pharmaceutical company she was responsible for managing the patent portfolios for both marketplace pharmaceutical products and a range of high-value development drug compounds.
Fiona has been a judge on a range of innovation awards and mentored a range of trainee attorneys and support staff.
Managing Intellectual Property IP Stars 2021, comprising the highly recommended IP professionals, has now been published. HGF is delighted to have 14 European attorneys listed. IP STARS is the leading …Read article
Pharmaceutical and biotechnology patent applications also make top 10 most patented. Recent statistics published by the EPO show that a total of 14,295 European patent applications were filed in 2020 …Read article
The 2021 EPO Guidelines provide much needed guidance on how to protect antibodies in Europe. Biological drugs including therapeutic antibodies have become increasingly important to the pharmaceutical industry. The European …Read article
Opportunities for additional pharmaceutical product patent protection in Europe, based on the use of a drug to treat a patient exhibiting a biomarker indicative of drug response. Recent years have …Read article
Exploring the growth of patents for connected medical devices, and how best to protect them. The Internet of Things (IoT) is expected to change our lives by creating a connected …Read article
To waive, or not to waive, that is the question. The earliest identified date of a patient presenting with symptoms of a “novel coronavirus” in Wuhan, China is reported to …Read article
HGF in Europe and Knobbe Martens in the US are holding a joint webinar on 9th June. In this webinar we will explore considerations for implementing an effective strategy to …Event details
HGF Partner Dr Susan Keston and Senior Patent Attorney Dr Sofie McPherson will be presenting a webinar ‘How to capitalise on the 5G healthcare revolution’ on 25th May. This session will explore how 5G …Event details
If you would like to discuss how HGF could help you, contact one of our IP specialists.